Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-11

Clinical Trial Update: An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

View source ↗

Summary

This terminated observational study evaluated how long resistance mutations persist and whether sustained virologic response endures in patients with chronic he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct-acting antiviral (DAA) containing regimens (Direct-acting antivirals)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: TERMINATED | Results posted: 2016-03-11